Filing excerpt
On August 4, 2026, the Company announced that Jennifer Taubert will retire from her position as Executive Vice President, Worldwide Chairman, Innovative Medicine and member of the Executive Committee effective September 1, 2026.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-8kgovernanceChangeGet every 8-K signal for Johnson & Johnson and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Johnson & Johnson this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/dd6ea01f-be0d-4b02-9f46-b72652ca96d4 returns this record as JSON. POST /v1/companies/enrich returns every signal for jnj.com.
{
"signal_id": "dd6ea01f-be0d-4b02-9f46-b72652ca96d4",
"signal_type": "sec-8k",
"signal_subtype": "governanceChange",
"detected_at": "2026-08-11T08:07:21.836+00:00",
"company": {
"name": "Johnson & Johnson",
"domain": "jnj.com"
},
"data": {
"detail": "The retirement of the Executive Vice President for the key Innovative Medicine division creates a window of opportunity. New leadership will likely re-evaluate strategic priorities, budgets, and vendor relationships for this major business segment, opening doors for new solutions.",
"metrics": {
"timeframe": "immediate"
},
"summary": "J&J's Head of Innovative Medicine, Jennifer Taubert, to retire effective September 1, 2026",
"excerpts": "On August 4, 2026, the Company announced that Jennifer Taubert will retire from her position as Executive Vice President, Worldwide Chairman, Innovative Medicine and member of the Executive Committee effective September 1, 2026.",
"relevance": 0.9,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/200406/000020040626000167/jnj-20260804.htm",
"filing_date": "2026-08-04",
"filing_year": 2026,
"fiscal_year_end": "08/04",
"sales_relevance": "Governance tools needed",
"signal_category": "esg",
"regions_mentioned": [
"Worldwide"
]
}
}
curl https://signals.autobound.ai/v1/signals/dd6ea01f-be0d-4b02-9f46-b72652ca96d4 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"jnj.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.